Navigation Links
Manor Care, Inc. Stockholders Approve Proposed Merger
Date:10/17/2007

TOLEDO, Ohio, Oct. 17 /PRNewswire-FirstCall/ -- Manor Care, Inc. (NYSE: HCR) announced that at its special meeting of stockholders today, the company's stockholders approved the merger agreement providing for the merger of Manor Care, Inc. with an affiliate of The Carlyle Group. Approximately 99 percent of the shares present and voting voted for the approval of the merger agreement. The number of shares voting to approve the merger agreement represents approximately 76 percent of the total number of shares outstanding and entitled to vote.

Under the terms of the merger agreement, upon the completion of the merger, Manor Care, Inc. stockholders generally will be entitled to receive $67.00 in cash for each share of Manor Care, Inc. common stock held. The merger, which remains subject to receipt of certain regulatory approvals and other customary closing conditions, is expected to close in the fourth quarter of 2007.

Manor Care, Inc., through its operating group HCR Manor Care, is a leading provider of short-term post-acute services and long-term care. The company's nearly 60,000 employees provide quality care for patients and residents through a network of more than 500 skilled nursing and rehabilitation centers, assisted living facilities, outpatient rehabilitation clinics, and hospice and home care agencies. The company operates primarily under the respected Heartland, ManorCare Health Services and Arden Courts names. Shares are traded on the New York Stock Exchange under the ticker symbol HCR.


'/>"/>
SOURCE Manor Care, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Child Health: Orphanage vs. Foster Care, A Study
2. Adult Heart Care, Cause of Heart ache in Europe.
3. The Costliest Flu Ever – This Bird-Flu Scare, Aint chicken feed
4. Bariatric Surgery: Medicare, Will Now Cough Up For ‘Throwing Weight
5. Adequate Foot Care, the Only Way to Prevent Amputation of Lower Limbs in Diabetics
6. NEW ROBOTIC SURGERY ARM APPROVED BY FDA
7. Abortion Pill approved by FDA
8. Another injectable contraceptive Pill approved by FDA
9. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
10. New FDA Approved Drug To Treat Migraine
11. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... (UCAOA) and College of Urgent Care Medicine will host industry leaders for the ... speakers will help those in the industry adapt to the issues currently affecting ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to meet talent shortages ... outdated healthcare executive resume. , “If you’re a healthcare executive open to new opportunities ... if it’s as ready as you are for a new job search. I’ve heard ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: